Loading...
•
Dec 31, 2025
Quest Diagnostics Q4 2025 Earnings Report
Quest Diagnostics reported strong fourth quarter and full year 2025 financial results, with double-digit growth in revenues and earnings per share, and provided guidance for full year 2026.
Key Takeaways
Quest Diagnostics closed 2025 with a strong fourth quarter, achieving a 7.1% increase in revenues to $2.81 billion and an 11.8% increase in reported diluted EPS to $2.18. For the full year, revenues grew 11.8% to $11.04 billion and reported diluted EPS increased 13.8% to $8.75. The company also announced a 7.5% increase in its quarterly dividend to $0.86 per share and provided optimistic guidance for 2026.
Fourth quarter revenues increased by 7.1% to $2.81 billion, demonstrating strong performance.
Reported diluted EPS for the fourth quarter rose by 11.8% to $2.18, reflecting improved profitability.
Full year revenues reached $11.04 billion, an 11.8% increase from 2024, and full year reported diluted EPS grew 13.8% to $8.75.
The company increased its quarterly dividend by 7.5% to $0.86 per share, signaling confidence in future performance.
Revenue by Segment
Forward Guidance
Quest Diagnostics expects continued growth in 2026, with projected revenues between $11.70 billion and $11.82 billion, and adjusted diluted EPS between $10.50 and $10.70. The company anticipates strong cash flow from operations and manageable capital expenditures.
Positive Outlook
- Full year 2026 revenues are expected to increase by 6.0% to 7.1%, reaching between $11.70 billion and $11.82 billion.
- Adjusted diluted EPS for 2026 is projected to be between $10.50 and $10.70, indicating strong profitability.
- Cash provided by operations is estimated at approximately $1.75 billion, reflecting robust cash generation.
- The company anticipates continued execution of its strategy, including clinical innovations and strategic collaborations.
- The guidance reflects confidence in business strengths and market fundamentals.
Challenges Ahead
- Estimated pre-tax charges of $12 million for restructuring and integration costs will impact earnings.
- Estimated pre-tax net charges of $12 million associated with changes in the fair value of contingent consideration will affect profitability.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...